AI Images: Where Seeing Isn’t Believing

Up until now, we've evaluated the trustworthiness of where information comes from, how it’s been generated, and the context in which it’s presented. But the newest generation of imaging tools threatens to change that.

Harvard’s AI Guidance: A Lesson in Binary Thinking

In an era where ChatGPT will soon be as common as calculators, Harvard's stance on AI in the classroom should be more than a binary decision — it should be an open dialogue that empowers students to navigate the AI landscape with wisdom and creativity.

150 Years, 9 Lives: Stories from The Harvard Crimson

In truth, the legacy of The Crimson is not contained in books; it’s in the people who have sustained it. Here are just nine of them.

Learning to Forget

It’s hard to resist the constant urge to document. But memory is just as much about forgetting as it is about remembering.

Harvard Corporation Political Donations in 2021 and 2022 Pie Chart

Harvard Corporation Political Donations in 2021 and 2022

Rewriting Our Harvard Admissions Essays

In this series of introspections, six Crimson editors revisit the essays that got them into Harvard.

Taking the Bait

College admissions for selective institutions have no longer become a competition of test grades or grade point averages, but a race to the bottom to demonstrate prodigious authenticity.

Charles Lieber’s Trial Begins Tuesday: Here’s What You Need to Know

Former Harvard Chemistry chair Charles M. Lieber is set to stand trial Tuesday on six federal charges related to his ties to the Chinese government, nearly two years after his initial arrest.

Experts Say Lieber Trial Could Decide Fate of DOJ’s China Initiative

As former Harvard Chemistry chair Charles M. Lieber goes on trial on federal charges beginning Tuesday, law and trade experts speculated that his case’s outcome could decide the fate of the Department of Justice’s China Initiative.